In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae [2]

International Journal of Antimicrobial Agents

Volumn 20, Issue 5, 2002, Pages 395-398

  Neuhauser, Melinda M ^a   Jung, Rose ^b   Danziger, Larry H ^c   Pendland, Susan L ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CETHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; PENICILLIN G; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; KETOLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DILUTION; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; KETOLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036844793     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00197-8     Document Type: Letter

References (10)

1. Brueggemann A.B., Doern G.V., Huynh H.K., Wingert E.M., Rhomberg P.R. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44:2000;447-449.
2. Nishijima T., Saito Y., Aoki A., Toriya M., Toyonaga Y., Fujii R. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43:1999;637-643.
3. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobialsusceptibility tests for bacteria that grow aerobically, fifth ed., Approved standard M7A5Wayne, PA, 2000.
4. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. Wayne, PA, 2000.
5. Davies T.A., Ednie L.M., Hoellman D.M., Pankuch G.A., Jacobs M.R., Appelbaum P.C. Antipneumococcal activity of ABT-773 compared to those of 10 other agents. Antimicrob. Agents Chemother. 44:2000;1894-1899.
6. Credito K.L., Lin G., Pankuch G.A., Bajaksouzian S., Jacobs M.R., Appelbaum P.C. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents. Antimicrob. Agents Chemother. 45:2000;67-72.
7. Odenholt I., Löwdin E., Cars O. Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens. Antimicrob. Agents Chemother. 45:2001;23-29.
8. Biedenbach D.J., Barret M.S., Jones R.J. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains. Diagn. Microbiol. Infect. Dis. 31:1998;349-353.
9. Boswell F.J., Andrews J.M., Wise R. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci, and Bacteroides fragilis. J. Antimicrob. Chemother. 41:1998;149-153.
10. Pankuch G.A., Hoellman D.B., Lin G., Bajaksouzian S., Jacobs M.R., Appelbaum P.C. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob. Agents Chemother. 42:1998;3032-3034.